BriaCell Therapeutics Corp. (BCTX)
3.435
+0.02
(+0.73%)
USD |
NASDAQ |
Oct 23, 16:00
3.42
-0.02
(-0.44%)
After-Hours: 20:00
BriaCell Therapeutics EPS Diluted (Quarterly) : -0.9881 for April 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.9881 |
| January 31, 2026 | -2.577 |
| October 31, 2025 | -4.351 |
| July 31, 2025 | -4.295 |
| April 30, 2025 | -16.40 |
| January 31, 2025 | -23.31 |
| October 31, 2024 | -0.2178 |
| July 31, 2024 | -0.0673 |
| April 30, 2024 | 0.1074 |
| January 31, 2024 | -0.7067 |
| October 31, 2023 | -0.4966 |
| July 31, 2023 | -0.1513 |
| April 30, 2023 | -0.3155 |
| January 31, 2023 | -0.7657 |
| October 31, 2022 | -0.0713 |
| April 30, 2022 | -97.82 |
| January 31, 2022 | 90.95 |
| October 31, 2021 | -271.02 |
| April 30, 2021 | 93.26 |
| January 31, 2021 | -0.2917 |
| October 31, 2020 | -0.4751 |
| July 31, 2020 | -0.7048 |
| April 30, 2020 | -0.7044 |
| January 31, 2020 | -1.981 |
| October 31, 2019 | -1.824 |
| Date | Value |
|---|---|
| July 31, 2019 | -1.949 |
| April 30, 2019 | -87711.45 |
| January 31, 2019 | -2.189 |
| October 31, 2018 | -1.504 |
| July 31, 2018 | -3.103 |
| April 30, 2018 | -2.352 |
| January 31, 2018 | -2.371 |
| October 31, 2017 | -2.399 |
| July 31, 2017 | -2.271 |
| April 30, 2017 | -386.91 |
| January 31, 2017 | -0.932 |
| October 31, 2016 | -1.090 |
| July 31, 2016 | -0.9259 |
| April 30, 2016 | -1.134 |
| January 31, 2016 | -2.185 |
| October 31, 2015 | -1.085 |
| July 31, 2015 | -1.055 |
| April 30, 2015 | -2.402 |
| January 31, 2015 | -10.30 |
| October 31, 2014 | -2.012 |
| July 31, 2014 | -126.16 |
| April 30, 2014 | -8.825 |
| January 31, 2014 | -1.404 |
| October 31, 2013 | -2.603 |
| July 31, 2013 | -1.711 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -0.6003 |
| ProMIS Neurosciences, Inc. | -1.283 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.237M |
| Total Expenses (Quarterly) | 7.164M |
| Enterprise Value | 1.452M |
| Earnings Yield | -355.5% |
| Normalized Earnings Yield | -362.85 |